LifeTech Scientific Corporation (01302) released its October 2025 Monthly Return, highlighting no changes in authorized or issued share capital compared to the previous month. The authorized share capital remains at 40,000,000,000 ordinary shares, with a total value of USD 50,000. The issued share capital remains at 4,631,712,400 ordinary shares.

Under the Share Option Scheme approved on 22 October 2011, 25,590,000 options remained outstanding at the start of the period. Under the Share Option Scheme approved on 17 September 2021, 284,935,000 options were outstanding at the start of the period, with 150,000 options lapsed during the month, resulting in a balance of 284,785,000. No new shares were issued, no treasury shares were transferred, and there were no other warrants or convertibles reported for the period under review.